epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Kisqali
    ribociclib
  • remove Maxitrol
    neomycin/ polymyxin B/ dexamethasone ophthalmic
  • remove Myrbetriq
    mirabegron
  • remove Previfem
    norgestimate/ ethinyl estradiol

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Kisqali (ribociclib) + Previfem (norgestimate/ ethinyl estradiol)

Monitor/Modify Tx


ribociclib + ethinyl estradiol (contraceptive)

monitor ECG, electrolytes, CBC, thrombosis s/sx, especially if oral ethinyl estradiol dose >35 mcg/day: combo may incr. levels of both drugs, risk of QT prolongation, cardiac arrhythmias, myelosuppression, thromboembolism, other adverse effects (hepatic metabolism inhibited)

Smiley face Smiley face Myrbetriq (mirabegron) + Previfem (norgestimate/ ethinyl estradiol)

Monitor/Modify Tx


mirabegron + ethinyl estradiol (contraceptive)

monitor BP: combo may incr. risk of HTN (additive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information